Brazilian Journal of Cardiovascular Surgery
- Purpose and Editorial Policy
- Research with Human Subjects and Experimental Studies
- Ethical Considerations
- Use of Inclusive Language
- Preprints
- Quality Standards
- Types of Manuscript
- Manuscript Preparation
- Manuscript Evaluation Process
- Electronic Submission
- Proofs
1. Purpose and Editorial Policy
The Brazilian Journal of Cardiovascular Surgery (BJCVS) is the
official publication of the Sociedade Brasileira de Cirurgia
Cardiovascular (SBCCV). It is a peer-reviewed scientific journal,
published on a rolling basis and with regular circulation since
1986.
BJCVS aims to register the scientific production and innovation
in cardiovascular surgery and encourage continuous education,
professional improvement, and the ongoing development of
specialty professionals. With its commitment to these goals,
BJCVS has a significant impact on cardiovascular surgery
practice and related fields.
BJCVS follows the recommendations set by the International
Committee of Medical Journal Editors (ICMJE - www.icmje.
org), the Committee on Publication Ethics (COPE - https://
publicationethics.org/), the Council of Science Editors (CSE
- https://www.councilscienceeditors.org/) and the World
Association Medical Editors (WAME - http://www.wame.org/).
BJCVS welcomes the submission of papers focusing on topics
related to cardiovascular surgery and its associated areas. BJCVS
also accepts preprints, which are preliminary versions of a work
shared publicly before going through the formal peer review
process and publication in a journal. The journal publishes
the following categories of articles: Original Articles, Review
Articles, Brief Communications, How I Do It, Multimedia, Letter
to the Editor, Editorial and Guidelines.
The acceptance of articles will be based on their originality,
significance, and scientific contribution to the field. Articles
with purely propagandistic or commercial purposes will not be
accepted.
Articles should be submitted only in English, using clear and
precise language while avoiding colloquial (informal) writing.
Only manuscripts whose data are not being evaluated by other
journals and/or which have not been previously published will
be considered for evaluation. Once approved, reproduction of
the manuscripts, whether in whole or in part, requires explicit
consent from the BJCVS editor. Keep your registration updated,
as communication with the authors is conducted exclusively
by email..
The journal will be published in its entirety on the website
www.bjcvs.org and on SciELO at www.scielo.br/rbccv, with
specific links on the website of SBCCV (www.sbccv.org.br) and
CTSNET (www.ctsnet.org).
Recognizing the importance of disseminating the published
articles, BJCVS is indexed in the main international databases:
Web of Science (Clarivate Analytics), PubMed Central, PubMed/
Medline, SCOPUS (SCImago), Proquest, LATINDEX, Redalyc, EBSCO, and Google Scholar. Moreover, it is also indexed in
national databases: LILACS and SciELO.
BJCVS does not charge any Article Processing Charge (APC) for
the submission, evaluation, review, publication, distribution, or
downloading of manuscripts. Publication is completely free
and open access.
2. Research with Human Subjects and Experimental Studies
Research involving human subjects must be submitted to
the Ethics Committee of the institution, in accordance with
the Declaration of Helsinki of 1975, revised in 2013 (available
at Research involving human subjects must be submitted to
the Ethics Committee of the institution, in accordance with
the Declaration of Helsinki of 1975, revised in 2013 (available
at https://www.wma.net/policies-post/wma-declaration-ofhelsinki-ethical-principles-for-medical-research-involvinghuman-subjects/#:~:text=The%20World%20Medical%20
Association%20(WMA,identifiable%20human%20material%20
and%20data. ) and Resolution 466/2012 of the Brazilian National
Health Council (available at http://bvsms.saude.gov.br/bvs/
saudelegis/cns/2013/res0466_12_12_2012.html). ) and Resolution 466/2012 of the Brazilian National
Health Council (available at http://bvsms.saude.gov.br/bvs/
saudelegis/cns/2013/res0466_12_12_2012.html).
Manuscripts must be accompanied by a statement confirming
that the research was carried out with the informed and
appropriate consent of everyone involved. Written consent
must be obtained from the patient (or their legal guardian
or executor, if applicable) for publication of any details or
photographs that could identify an individual.
Experimental work involving animals must comply with the
ARRIVE (Animal Research: Reporting of In Vivo Experiments)
and PREPARE (Planning Research and Experimental Procedures
on Animals: Recommendations for Excellence) guidelines,
which must be applied in addition to the Brazilian Guideline
for Animal Care and the Use of Animals in Teaching or Scientific
Research Activities (DBCA), from the Brazilian National Council
for the Control of Animal Experimentation (CONCEA).
3. Ethical Considerations
BJCVS supports the recommendations of the Committee on
Publication Ethics (COPE), the Council of Science Editors (CSE)
and the World Association Medical Editors (WAME) regarding
ethical standards of publication, addressing plagiarism,
self-plagiarism, redundant publication, data fabrication, and
corrections and retractions. Any cases of misconduct will be dealt with the appropriate sanctions established by the
Editorial Board.
- Plagiarism is the appropriation of someone else's
ideas, processes, results, or words without proper
acknowledgment. Authors hold full responsibility for the
content and information presented in their manuscripts.
BJCVS uses the Similarity Check software, which allows to
detect similarities in the submitted materials. Manuscripts
found to contain plagiarism will be rejected, and
authors may incur sanctions determined by the
Editorial Board.
- Text Recycling, also known as self-plagiarism, is the
practice of reusing some or all the content of a previous
work without proper attribution or proper citation in a
new work. This can include reusing entire sections from
a previous publication or mixing excerpts from different
previous works. In other words, text recycling occurs when
an author incorporates excerpts from their own previously
published work into a new work, without indicating that
these excerpts have been published before. This practice
is considered unethical because it can be seen as an
attempt to deceive the reader by presenting information
as new and original when it has already been previously
published. Manuscripts that present text recycling
will be rejected, and authors may incur sanctions
determined by the Editorial Board.
- Duplicate Submission and Redundant Publication: The BJCVS is committed to publishing only original
material that has not been previously published or is
under review by other journals, including in languages
other than English. Articles submitted to the BJCVS
should not be submitted to any other journal while under
evaluation. Duplicate submission refers to the practice
of submitting the same study to multiple journals, while
redundant publication involves the inappropriate division
of study results into multiple articles (also known as salami
publication), which may result in the rejection or retraction
of the article, and authors may face sanctions established
by the BJCVS Editorial Board.
- Data Fabrication and Falsification: If any fraud in the
manipulation of images, data fabrication or falsification is
identified in a manuscript, it will be promptly excluded
from the evaluation process and authors may face
sanctions determined by the Editorial Board.
- Corrections and Retractions: Errors or failures, regardless of their nature or origin, that do not constitute misconduct will be corrected by erratum. In articles already published in which misconduct has been identified, retraction will be made
stating the reason for the retraction properly referenced. All authors will be asked to agree to the content.
- Conflict of Interest Statement: BJCVS requests that all authors declare any financial, personal, or organizational relationships that may inappropriately influence (bias) their work. Authors must disclose a possible conflict of interest, in addition
to the liability of any violation. For more information on conflict of interest, BJCVS recommends consulting the ICMJE (http://www.icmje.org/conflicts-of-interest/) and
WAME (http://wame.org/wame-editorial-on-conflict-of-interest) guidelines.
Conflicts include:
- Financial - funding and other payments, goods or
services received or expected by the authors related to
the subject of the work, or from organizations with an
interest in the result of the work.
- Affiliations – being employed, serving on the advisory
board, or being a member of an organization with an
interest in the outcome of the work.
- Intellectual property – ownership of patents or
trademarks by the authors or their organization
- Personal - Friends, family, relationships, and other close personal connections.
- Ideological – beliefs or activism, such as political or
religious affiliations, relevant to the work
- Academic - Competitors or someone whose work is criticized.
If there is no conflict, the authors must declare no conflict of interest.
that they have no conflicts to declare. Any conflicts of interest must be disclosed at the time of
manuscript submission by the ScholarOne system.
- Use of chatbots in manuscripts submitted to BJCVS:in order to ensure the integrity and reliability of the results
and conclusions presented in scientific manuscripts that
use chatbots such as ChatGPT, and to maintain public
confidence in the findings and advances presented, BJCVS
supports WAME recommendations (https://wame.org/
page3.php?id=106) on the ethical considerations related
to these technologies in scientific manuscripts, namely
- Transparency:Authors should be transparent about
the use of chatbots in the manuscript writing process,
including detailed information (name, version, model
and source of the technology used), as well as explaining
the role of chatbots in the development of the text.
- Responsibility:Authors are responsible for the work
performed by chatbots in their manuscripts, including
the accuracy of the information presented and the
absence of plagiarism. Authors should also be able to
state that there is no plagiarism in their article, including
in the text produced by chatbots.
- Attribution: Authors must ensure proper attribution
of all sources, including material produced by chatbots.
Authors should also seek out and cite sources that
support statements made by chatbots.
- Limitations:Authors should discuss the limitations and
potential biases associated with using chatbots in the
production of scientific texts.
Authors should disclose the use of generative artificial
intelligence (AI) and AI-assisted technologies in the writing
process by including a statement in the main manuscript file
before the References section. The statement should be
presented in a new section titled “Declaration of Generative
AI and AI-Assisted Technologies in the Writing Process”.
- Statement: “During the preparation of this work, the
author(s) used [NAME OF THE TOOL/SERVICE] for the
purpose of [REASON]. After using this tool/service, the
author(s) have reviewed and edited the content as
necessary and assume full responsibility for the content of
the publication”.
This statement does not apply to the use of basic tools
for grammar and spelling checking and reference
management, among others. If there is nothing to reveal,
there is no need to add a statement.
- Originality and Copyright Statement: Authors retain
the copyright to their articles and agree to grant BJCVS the
license to publish, provided that the authorship is properly
credited and that the original article is quoted correctly.
By submitting the manuscript, the authors declare that
the work is original and does not contain fabrication,
fraud, or plagiarism; does not infringe any copyright or
property rights of third parties; is not under consideration
for publication in another journal; and has not been
previously published. In addition, authors must ensure that
they meet the authorship requirements as recommended
by the ICMJE (please refer to the Manuscript Preparation
section) and understand that, if the article or part of it is
found to be flawed or fraudulent, each author bear shared
responsibility
- Sanctions: Practices that harm scientific integrity such as Plagiarism, Self-Plagiarism, Duplicate Publication and Redundant Publication will be taken for evaluation by the Editorial Board for decision on penalties such as suspension for
a period determined by the Editorial Board. Authors will be immediately notified of all steps of this process.
4.Use of Inclusive Language
Inclusive language is sensitive to differences and promotes
equal opportunities, respecting individual differences, and
avoiding any implication of superiority based on age, gender, race, ethnicity, culture, sexual orientation, disability, or health
status. BJCVS advises authors to ensure that their manuscripts
are free of prejudice, stereotypes, slang, and references to
dominant cultures, in addition to avoid using descriptors that
refer to irrelevant personal attributes. To strive for gender
neutrality and to avoid using offensive or exclusionary terms
in coding terminology, BJCVS recommends the use of plural
nouns. For more information, authors are encouraged to
refer to chapter 11 of the AMA Manual of Style, 11th edition, at
https://academic.oup.com/amamanualofstyle/book/27941/
chapter/207567296?login=true#362714659.
5.Preprints
BJCVS recognizes the value of new scientific media and enables
readers and researchers to have faster access to the results of
recent research prior to its publication. Therefore, BJCVS accepts
manuscripts that have been deposited on non-commercial
preprint servers.
Preprints are preliminary versions of scientific works that are
publicly shared in online repositories prior to its peer review
and publication in a scientific journal. It is a way to accelerate
the process of scientific communication, allowing researchers
to promptly share their findings with the academic community.
Preprints can be found in public repositories such as bioRxiv
and medRxiv, which are platforms dedicated to biology and
medicine publications, respectively. These repositories are
maintained by non-profit organizations and offer free access to
the public for reading and downloading.
To ensure transparency and integrity in the handling of
preprints submitted to the BJCVS, authors are encouraged to
provide the following information:
- Preprint identification: Authors must provide detailed
information about the preprint, including title, authors,
name of the repository where it was published, date of
publication and Digital Object Identifier (DOI) if available
- Relationship with the submitted work: Authors should
clearly explain the relationship between the preprint and
the work submitted to the journal, e.g., if the preprint is
an earlier version of the submitted work or if it contains
supplementary information.
- Conflict of interest: Authors must disclose any conflicts
of interest related to the preprint, such as funding from a
company or institution with an interest in the work.
BJCVS recommends completing the Open Science Compliance
Form, that must be submitted as a Supplementary File
together with the manuscript. This information is important
for the BJCVS editors to evaluate the originality and relevance
of the submitted work, as well as to avoid duplication or
redundant information in subsequent publications.
6.Quality Standards
BJCVS requires all submitted articles to meet the quality standards set by the guidelines for producing health research reports - Enhancing the Quality and Transparency of Health Research (EQUATOR) Network (https://www.equator-network.org/):
6.1 Clinical Trials
Clinical trial registration: BJCVS supports the World Health Organization (WHO) and ICMJE clinical trial registration policies, recognizing the importance of these initiatives for the registration and international dissemination of open access clinical
trial data. Therefore, only clinical research articles that have received an identification number in one of the Clinical Trials Registries recognized by WHO and ICMJE (Brazilian Clinical Trial Registry - REBEC - http://www.ensaiosclinicos.gov.br/ or http://apps.who.int/trialsearch/default.aspx) will be accepted for publication. The registration identification
number must be given in the "Methods" section.
Randomized trials should follow the CONSORT guidelines (http://www.consort-statement.org). This statement provides an evidence-based approach to improving the quality of clinical trial
reports. All manuscripts describing a clinical study should include the CONSORT Flow Diagram showing the number of participants in each intervention group, as well as a detailed description of how many patients were excluded at each step from
the data analysis. All clinical trials must be registered and made available on an open access website. The trial protocol (including the complete statistical analysis plan) should be submitted with the manuscript.
6.2 Data Sharing Statement
As recommended by the ICMJE and the BJCVS, clinical trials
must include a data sharing statement. This statement should
specify: the individual patient data, a data dictionary that defines
each field in the dataset and supporting documentation (e.g.,
statistical/analytical code), that will be shared; details on when,
where, and how the data is available (informing the access
link to the data repository); types of analyses that are allowed;
and if there are restrictions on the use of the data. If there any
reasons why the data cannot be shared, an explanation should
be provided. Examples of data sharing statements that meet
ICMJE requirements are available at http://www.icmje.org/
news-and-editorials/data_sharing_june_2017.pdf.
7. Types of Manuscript
- Original Article: Articles reporting new and/or innovative results for cardiovascular surgery. This category includes clinical trials, cohort studies, case-control, prevalence, incidence, accuracy and cost-benefit studies, cross-sectional
studies, epidemiological and experimental assessments, among other observational studies, and should contain:
| Maximum Title length (words) |
40 |
| Running title (words) |
12 |
| Maximum Abstract length (words) |
250 |
| Maximum length excluding abstract, tables, figures and references (words) |
5,000 |
| Maximum number of figures and tables |
08 |
| Maximum number of references |
25 |
-
Review Article: Studies that use systematic methods and explicit criteria to identify, select and critically evaluate relevant research. This category includes systematic review with and without meta-analyzes
| Maximum Title length (words) |
40 |
| Running title (words) |
12 |
| Maximum Abstract length (words) |
250 |
| Maximum length excluding abstract, tables, figures and references (words) |
6500 |
| Maximum number of figures and tables |
08 |
| Maximum number of references |
75 |
The BJCVS requests that authors register their systematic
reviews on platforms such as Prospero (https://www.crd.york.
ac.uk/prospero/) and include the registration number in the
Methods section. Prospero is an international database of
systematic reviews and meta-analyses, which aims to enhance
the transparency and quality of these studies. Registering a
systematic review in Prospero helps ensure that the research
is planned and conducted in an appropriate and transparent
manner
-
Brief Communication: Articles intended to promptly
share newly obtained results on topics of great interest.
This type of article primarily focuses on innovative
hypotheses that are likely to establish new paradigms in
the field of cardiovascular surgery. Authors should adhere
to the following guidelines:
| Maximum Title length (words) |
40 |
| Running title (words) |
12 |
| Maximum Abstract length |
100 |
| Maximum length excluding Abstract, tables, figures and references (words) |
1,500 |
| Maximum number of figures and tables |
02 |
| Maximum number of references |
20 |
-
How I Do It: Articles that address procedures with distinct
or innovative characteristics in the field of cardiovascular
surgery.
| Maximum Title length (words) |
40 |
| Running title (words) |
12 |
| Maximum Abstract length (words) |
100 |
| Maximum length excluding abstract, tables, figures and references (words) |
1,500 |
| Maximum number of figures and tables |
08 |
| Maximum number of references |
10 |
-
Multimedia: Modality that allows the submission of videos
(MP3 or MP4 format) or images that provide valuable
insights into significant disease states or their treatments.
The multimedia submission should adhere to the following
requirements:
| Maximum Title length (words) |
40 |
| Running title (words) |
12 |
| Maximum length excluding abstract, tables, figures and references (words) |
1,500 |
| Maximum number of videos |
02 |
| Maximum number of figures |
04 |
| Maximum number of references |
08 |
-
Letters to the Editor: Letters to the editor provide an
opportunity for readers to express their comments,
discuss or criticize articles published in the BJCVS, as well
as address other topics of general interest.
| Maximum Title length (words) |
40 |
| Running title (words) |
12 |
| Maximum length excluding abstract and references (words) |
1,000 |
| Maximum number of references |
06 |
-
Editorial: By invitation only.
-
Guidelines: Only at the discretion of the Department Boards
of the Sociedade Brasileira de Cirurgia Cardiovascular..
8. Manuscript Preparation
Manuscripts must be submitted in Microsoft Office Word file,
with mandatory configuration of A4 paper pages (210x297 mm) and 2 cm margins on all sides. The recommended font is Times
New Roman size 12 and the text should have a line spacing of
1.5 pt.
The Letter to the Editor should be sent separately from the
manuscript and should inform the reasons why the BJCVS was
selected for submission, including mentioning the scientific
contributions of the manuscript to the subject matter.
The BJCVS follows a double-anonymous peer review process,
which is performed by three or more reviewers assigned to
evaluate the articles. Throughout the evaluation process, the
identities of reviewers and authors are hidden from each other.
To facilitate the submission process, the BJCVS recommends
that authors prepare their manuscripts in separate files, as
described below:
Title Page:
1. Title and Authorship:
-
For individuals who do not meet the authorship criteria
but have contributed to the study, they must be listed
in the Acknowledgments section, as well as financial
support from funding agencies.
2.Manuscript Structure
-
The articles should be divided according to the study
design and follow the recommendations of the EQUATOR
Network (https://www.equator-network.org/):
-
Original Articles and Rapid Research Communications: Introduction, Methods, Results, Discussion, Conclusion,
Acknowledgments, and References.
-
Review Articles and Cutting-edge Reviews: Can be
structured in sections at the discretion of the author.
-
Case Reports: Introduction, Case Report and Conclusion.
-
Multimedia: Patient Characterization and Description
of the Technique Employed.
-
Special Articles (New Techniques, Letter to the Editor,
Editorial and Guidelines): Can be structured in sections
at the discretion of the author.
| Manuscript Structure (Checklist) |
|
Abstract
Structure |
Manuscript
Structure |
| Original Article
Review Article |
Introduction
Methods
Results
Conclusion |
Introduction
Methods
Results
Discussion
Conclusion
Funding (if any)
Acknowledgments
References |
| Brief
Communication |
Unstructured |
Introduction
Comments
References |
| How I Do It |
Unstructured |
Introduction
Technique or
Procedure
Discussion
Conclusion
References |
| Multimedia |
Unstructured |
Case Presentation
Description of the
Technique
Employed
Comment
References |
| Letter to the
Editor, Editorial
and Guidelines |
N/A |
N/A |
-
Abstract: it should be structured into four sections:
Introduction, Methods, Results, and Conclusion. It is
important to avoid the use of abbreviations. The maximum
number of words in the abstract should follow the
recommendations for each type of manuscript. In Case
Reports, the abstract should be structured into three
sections: Background, Case Presentation, and Conclusion.
In the New Techniques type, the abstract must be
unstructured. The Multimedia type does not require an
abstract.
-
Keywords: Three to five English descriptors should also
be included. Descriptors can be found at the following
electronic addresses: https://decsfinder.bvsalud.org/
dmfs (DeCS/MeSH Finder) or https://meshb.nlm.nih.gov/MeSHonDemand
(MeSH on Demand).
-
Abbreviations and Terminology: The use of
abbreviations should be kept to a minimum. When long
expressions need to be repeated, it is recommended to use
capitalized initials as replacements after the first mention,
followed by the initials in parentheses. All abbreviations
in tables and figures must be defined in the respective
captions. The BJCVS adopts the Universal Official
Anatomical Terminology, approved by the International
Federation of Associations of Anatomists (IFAA).
-
Units of Measurement: values of physical quantities must be reported according to the standards of the International System of Units.
-
Funding: Any sources of research assistance, including
project numbers and responsible institutions, must be
declared. The role of funding agencies in study design,
data collection, analysis and interpretation, and manuscript
writing should be also stated in the Acknowledgments
section.
-
Acknowledgments: All contributors who have made
substantial contributions to the manuscript (e.g., data
collection, analysis, and writing or editing assistance),
but do not meet the criteria for authorship, should be
mentioned, as well as their specific contributions, in the
Acknowledgments section.
-
References: References should be standardized according
to the Vancouver style, as specified by the International
Committee of Medical Journal Editors (examples of
references are available at https://www.nlm.nih.gov/bsd/
uniform_requirements.html).
References must be identified, in the body of the text,
with Arabic numerals, placed in superscript, and in square
brackets, obeying the order of their appearance in the text.
The accuracy of the references is the responsibility of the
author.
-
If more than two references are cited in sequence, only
the first and last references should be typed, separated
by a dash (Example: [6-9]). In cases of non-sequential
citation, all references must be typed and separated by
commas (Example: [6,7,9]).
-
Avoid citing theses, dissertations, books and chapters,
newspapers or non-scientific journals (magazines), and
articles “in press”, except when it is a theoretical reference
(e.g., Cochrane Handbook).
-
The BJCVS encourages the use of DOI, as it provides a
permanent access link to the electronic article.
-
For articles or texts published on the Internet that do not
have a DOI, provide the complete URL address, as well as
the date of access when it was consulted.
-
Preprint When a manuscript that has been published in
a preprint repository is later published as a peer-reviewed
article, the official publication should be referenced. Preprints that are fundamental to the development of
the manuscript or have significant advances in the field,
but have not yet been properly published, can be cited.
Preprints should be explicitly identified as such, for example:
- Li X, Lidsky P, Xiao Y, Wu CT, Garcia-Knight M, Yang J,
Nakayama T, Nayak JV, Jackson PK, Andino R, Shu X.
Ethacridine inhibits SARS-CoV-2 by inactivating viral
particles in cellular models. bioRxiv [Preprint]. 2020 Nov
2:2020.10.28.359042. doi: 10.1101/2020.10.28.359042
- Data Reference:The BJCVS encourages citation of
underlying or relevant datasets in the manuscript by
mentioning them in the text and including them in the
References section. Data references should include the
following elements: author(s) name(s), dataset title, data
repository, version (if available), year, and a global persistent
identifier. Examples:
- Research Data:Coin L. Genomics of development
and disease [dataset]. 2014 Jun 1 [cited 2017 Jun 9]. The
University of Queensland. Available from: http://dx.doi.
org/10.14264/uql.2016.583
- Repository Data: Dryad Digital Repository [Internet].
Durham (NC): Dryad. 2008 Jan - [cited 2014 Oct 3].
Available from: https://datadryad.org/stash/
- Data Deposited in Repositories: Kraemer MUG, Sinka
ME, Duda KA, Mylne A, Shearer FM, Brady OJ, Messina
JP, Barker CM, Moore CG, Carvalho RG, Coelho GE, Van
Bortel W, Hendrickx G, Schaffner F, Wint GRW, Elyazar
IRF, Teng H, Hay SI. The global compendium of Aedes
aegypti and Ae. albopictus occurrence [dataset]. 2015
Jun 30 [cited 2015 Oct 23]. In: Dryad Digital Repository
[Internet]. Durham (NC): Dryad. 2008 Jan - . 3 files: 3.406
MB; 1.549 MB; 1.815 MB. Available from: https://datadryad.
org/stash/dataset/doi:10.5061/dryad.47v3c. Referenced
in doi: 10.7554/eLife.08347
- Data Described in Articles: Kraemer MUG, Sinka ME,
Duda KA, Mylne A, Shearer FM, Brady OJ, Messina JP,
Barker CM, Moore CG, Carvalho RG, Coelho GE, Van Bortel
W, Hendrickx G, Schaffner F, Wint GRW, Elyazar IRF, Teng
H, Hay SI. The global compendium of Aedes aegypti
and Ae. albopictus occurrence [dataset]. Sci Data. 2015
Jul 7 [cited 2015 Oct 23];2:150035. Available from: http://
www.nature.com/articles/sdata201535. doi: 10.1038/
sdata.2015.35
-
Tables and Figures: : Tables and Figures must be numbered
in the order of their appearance in the text, have a title and
be submitted as separate files. Tables should not contain
redundant data already mentioned in the text. They
must have an open format with an all-white background.
The abbreviations used in tables must be mentioned in alphabetical order in the footer, with their respective
full forms. Likewise, the abbreviations used in figures
must be explained in the figure captions. Figures will be
published in color only if the author agrees to bear the
costs of printing. Only images in TIFF or JPEG formats will
be accepted, with minimum resolutions according to the
image type: 1200 dpi for simple black and white graphics,
300 dpi for black and white photographs and 600 dpi for
color photographs. Authors are requested to archive the
original images they possess in case there are any issues
with the submitted images, in which case the original
images may be requested.
-
Videos: Videos can be uploaded as Supplemental Files
along with the manuscript via ScholarOne. The accepted
digital formats are MPEG-4 and MP. Contributors must
be succinct, and editors reserve the right to require a
shorter video duration. The video must be of high quality
(both in content and visibility) and must demonstrate
the description provided in the manuscript. In addition,
the content of the video should directly correspond to
the video caption. Videos should not display explicit
advertising of any products. Educational presentations are
encouraged.
- Patient Consent: The corresponding author must confirm
in the Copyright Transfer Agreement (CTA) that they have
obtained a signed release form from each recorded video
authorizing its offline and/or online distribution. The BJCVS
suggests that patients should not be identified in the video.
Editors may request additional video editing from authors
prior to publication.
9. Manuscript Evaluation Process
The BJCVS follows a double-anonymous peer review process,
where three or more reviewers are assigned to evaluate the
articles. Throughout the evaluation process, the identities of
reviewers and authors are hidden from each other.
The Editor reviews the manuscript to determine its suitability for
the peer review process. If the manuscript is deemed to be of
insufficient quality or outside the scope of the journal, it should
be rejected without any further processing.
All scientific contributions are assessed by the Editor, Area
Associate Editors, Editorial Board Members and/or Guest
Reviewers, with the following processes:
| Adequacy to standards |
The initial analysis is conducted by the Editorial Assistant, to ensure compliance with the Author
Instructions. If the manuscript does not meet the established standards, it will be returned to
the authors for correction.
Once the manuscript is deemed appropriate to the Journal's standards, it is directed to the
Editor-in-Chief. |
| Evaluation Process |
The Editor-in-Chief assesses the quality and interest of the manuscript and forwards it to the
Associate Area Editor.
The Associate Area Editor evaluates the manuscript and refers it to three Reviewers. |
| Opinions |
The Reviewers submit their opinions directly in the ScholarOne system.
The Associate Editor, based on the opinions, makes the editorial decision:
• accept,
• revise,
• or reject
and the decision is forwarded to the Editor-in-Chief |
| Approval or Rejection |
The Editor-in-Chief decides on the approval for publication or rejection of the manuscript,
and the decision is communicated to the authors.
If the manuscript is accepted, it enters the publishing process for publication. |
9.1 Preprints Evaluation Process
Although the BJCVS follows the double anonymization peerreview process for manuscripts submitted to the journal, this
process cannot be implemented for preprints, since authors
and reviewers are known. However, the BJCVS adopts the
single anonymous process for preprints, in which reviewers are
known to the authors of the preprint, but not the other way
around. This ensures a critical and impartial evaluation of the
preprints before potential publication in the BJCVS
Whenever necessary, the BJCVS will ask the authors of the
preprints to provide detailed information on the methodology
used in the research, results obtained, and conclusions reached,
so that the reviewers can assess the quality of the work
appropriately
The BJCVS may also ask authors for information about any peer
review that the preprint has already undergone in another
repository, if applicable, to help reviewers in conducting a more
comprehensive evaluation of the preprint’s quality.
10. Electronic Submission
To submit a manuscript to the BJCVS, authors are required to
use the online submission system provided by ScholarOne,
at https://mc04.manuscriptcentral.com/rbccv-scielo. The
submission must include the following:
-
Letter of Presentation, explaining why the BJCVS was
chosen for submission. It should also highlight the scientific
contributions of the manuscript to the relevant subject
matter.
-
Conflict of interest statement of each author (the statement
must be completed via ScholarOne platform).
-
Title and Authorship Page.
-
Manuscript.
-
After manuscript accepted: Authors' Declaration duly
signed by all authors.
Each document must be attached separately in the designated
field within the ScholarOne system. Before initiating the process,
the person responsible for the submission must previously
register in the system as an author and create/associate their
ORCID registration – https://orcid.org/signin. All authors must
have the registration associated with an updated ORCID
11. Proofs
The corresponding author will receive a proof of the manuscript
in a text file (.doc and .docx), which includes observations and
changes made by the technical reading team. The author will
have four days to review the proof. If there are still questions
regarding the proof, the editorial team will contact the author
to address them, until a final version of the text is reached
Upon acceptance of the manuscript, the corresponding
authors will receive the finalized version of the article in PDF
format for approval. To open these files, Acrobat Reader needs
to be installed (available as a free download at http://get.
adobe.com/reader/). Corrections requested at this stage of the
process should be limited to typographical errors and should
not involve changes to the content of the study or the list of
authors. Once the proof is approved, authors must return the
approved version via email within 48 hours of receiving the
message. After the completion of the PDF production process,
the article will be sent for publication.
PDF
